
Anti-Infective Vaccines Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Insights into the Anti-Infective Vaccines Market include supply chain optimization, Anti-Infective Vaccines challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report describes the global market size of Anti-Infective Vaccines from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026.
For geography segment, regional supply, demand, major players, price is presented from 2016 to 2026. This report cover following regions:
North America
South America
Asia & Pacific
Europe
MEA
The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For competitor segment, the report include global key players of Anti-Infective Vaccines as well as some small players. The information for each competitor include:
Company Profile
Business Information
SWOT Analysis
Revenue, Gross Margin and Market Share
Applications Segment:
Bacterial diseases
Viral diseases
Types Segment:
Inactivated vaccines
Conjugate vaccines
Live/attenuated vaccines
Companies Covered:
Teva Pharmaceutical Industries
Emergent Biosolutions
Sanofi Pasteur
GlaxoSmithKline
Merck
CSL Limited
Astrazeneca
Pfizer
Serum Institute Of India
Protein Sciences Corporation
etc.
Please ask for sample pages for full companies list
Base Year: 2021
Historical Data: from 2016 to 2020
Forecast Data: from 2021 to 2026
Any special requirements about this report, please let us know and we can provide custom report.
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Anti-Infective Vaccines Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Anti-Infective Vaccines Market in North America (2016-2026)
8.1 Anti-Infective Vaccines Market Size
8.2 Anti-Infective Vaccines Market by End Use
8.3 Competition by Players/Suppliers
8.4 Anti-Infective Vaccines Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Anti-Infective Vaccines Market in South America (2016-2026)
9.1 Anti-Infective Vaccines Market Size
9.2 Anti-Infective Vaccines Market by End Use
9.3 Competition by Players/Suppliers
9.4 Anti-Infective Vaccines Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Anti-Infective Vaccines Market in Asia & Pacific (2016-2026)
10.1 Anti-Infective Vaccines Market Size
10.2 Anti-Infective Vaccines Market by End Use
10.3 Competition by Players/Suppliers
10.4 Anti-Infective Vaccines Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Anti-Infective Vaccines Market in Europe (2016-2026)
11.1 Anti-Infective Vaccines Market Size
11.2 Anti-Infective Vaccines Market by End Use
11.3 Competition by Players/Suppliers
11.4 Anti-Infective Vaccines Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Anti-Infective Vaccines Market in MEA (2016-2026)
12.1 Anti-Infective Vaccines Market Size
12.2 Anti-Infective Vaccines Market by End Use
12.3 Competition by Players/Suppliers
12.4 Anti-Infective Vaccines Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Anti-Infective Vaccines Market (2016-2021)
13.1 Anti-Infective Vaccines Market Size
13.2 Anti-Infective Vaccines Market by End Use
13.3 Competition by Players/Suppliers
13.4 Anti-Infective Vaccines Market Size by Type
Chapter 14 Global Anti-Infective Vaccines Market Forecast (2021-2026)
14.1 Anti-Infective Vaccines Market Size Forecast
14.2 Anti-Infective Vaccines Application Forecast
14.3 Competition by Players/Suppliers
14.4 Anti-Infective Vaccines Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Teva Pharmaceutical Industries
15.1.1 Company Profile
15.1.2 Main Business and Anti-Infective Vaccines Information
15.1.3 SWOT Analysis of Teva Pharmaceutical Industries
15.1.4 Teva Pharmaceutical Industries Anti-Infective Vaccines Revenue, Gross Margin and Market Share (2016-2021)
15.2 Emergent Biosolutions
15.2.1 Company Profile
15.2.2 Main Business and Anti-Infective Vaccines Information
15.2.3 SWOT Analysis of Emergent Biosolutions
15.2.4 Emergent Biosolutions Anti-Infective Vaccines Revenue, Gross Margin and Market Share (2016-2021)
15.3 Sanofi Pasteur
15.3.1 Company Profile
15.3.2 Main Business and Anti-Infective Vaccines Information
15.3.3 SWOT Analysis of Sanofi Pasteur
15.3.4 Sanofi Pasteur Anti-Infective Vaccines Revenue, Gross Margin and Market Share (2016-2021)
15.4 GlaxoSmithKline
15.4.1 Company Profile
15.4.2 Main Business and Anti-Infective Vaccines Information
15.4.3 SWOT Analysis of GlaxoSmithKline
15.4.4 GlaxoSmithKline Anti-Infective Vaccines Revenue, Gross Margin and Market Share (2016-2021)
15.5 Merck
15.5.1 Company Profile
15.5.2 Main Business and Anti-Infective Vaccines Information
15.5.3 SWOT Analysis of Merck
15.5.4 Merck Anti-Infective Vaccines Revenue, Gross Margin and Market Share (2016-2021)
15.6 CSL Limited
15.6.1 Company Profile
15.6.2 Main Business and Anti-Infective Vaccines Information
15.6.3 SWOT Analysis of CSL Limited
15.6.4 CSL Limited Anti-Infective Vaccines Revenue, Gross Margin and Market Share (2016-2021)
15.7 Astrazeneca
15.7.1 Company Profile
15.7.2 Main Business and Anti-Infective Vaccines Information
15.7.3 SWOT Analysis of Astrazeneca
15.7.4 Astrazeneca Anti-Infective Vaccines Revenue, Gross Margin and Market Share (2016-2021)
15.8 Pfizer
15.8.1 Company Profile
15.8.2 Main Business and Anti-Infective Vaccines Information
15.8.3 SWOT Analysis of Pfizer
15.8.4 Pfizer Anti-Infective Vaccines Revenue, Gross Margin and Market Share (2016-2021)
15.9 Serum Institute of India
15.9.1 Company Profile
15.9.2 Main Business and Anti-Infective Vaccines Information
15.9.3 SWOT Analysis of Serum Institute of India
15.9.4 Serum Institute of India Anti-Infective Vaccines Revenue, Gross Margin and Market Share (2016-2021)
15.10 Protein Sciences Corporation
15.10.1 Company Profile
15.10.2 Main Business and Anti-Infective Vaccines Information
15.10.3 SWOT Analysis of Protein Sciences Corporation
15.10.4 Protein Sciences Corporation Anti-Infective Vaccines Revenue, Gross Margin and Market Share (2016-2021)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Anti-Infective Vaccines Report
Table Data Sources of Anti-Infective Vaccines Report
Table Major Assumptions of Anti-Infective Vaccines Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Anti-Infective Vaccines Picture
Table Anti-Infective Vaccines Classification
Table Anti-Infective Vaccines Applications
Table Drivers of Anti-Infective Vaccines Market
Table Restraints of Anti-Infective Vaccines Market
Table Opportunities of Anti-Infective Vaccines Market
Table Threats of Anti-Infective Vaccines Market
Table Covid-19 Impact For Anti-Infective Vaccines Market
Table Raw Materials Suppliers
Table Different Production Methods of Anti-Infective Vaccines
Table Cost Structure Analysis of Anti-Infective Vaccines
Table Key End Users
Table Latest News of Anti-Infective Vaccines Market
Table Merger and Acquisition
Table Planned/Future Project of Anti-Infective Vaccines Market
Table Policy of Anti-Infective Vaccines Market
Table 2016-2026 North America Anti-Infective Vaccines Market Size
Figure 2016-2026 North America Anti-Infective Vaccines Market Size and CAGR
Table 2016-2026 North America Anti-Infective Vaccines Market Size by Application
Table 2016-2021 North America Anti-Infective Vaccines Key Players Revenue
Table 2016-2021 North America Anti-Infective Vaccines Key Players Market Share
Table 2016-2026 North America Anti-Infective Vaccines Market Size by Type
Table 2016-2026 United States Anti-Infective Vaccines Market Size
Table 2016-2026 Canada Anti-Infective Vaccines Market Size
Table 2016-2026 Mexico Anti-Infective Vaccines Market Size
Table 2016-2026 South America Anti-Infective Vaccines Market Size
Figure 2016-2026 South America Anti-Infective Vaccines Market Size and CAGR
Table 2016-2026 South America Anti-Infective Vaccines Market Size by Application
Table 2016-2021 South America Anti-Infective Vaccines Key Players Revenue
Table 2016-2021 South America Anti-Infective Vaccines Key Players Market Share
Table 2016-2026 South America Anti-Infective Vaccines Market Size by Type
Table 2016-2026 Brazil Anti-Infective Vaccines Market Size
Table 2016-2026 Argentina Anti-Infective Vaccines Market Size
Table 2016-2026 Chile Anti-Infective Vaccines Market Size
Table 2016-2026 Peru Anti-Infective Vaccines Market Size
Table 2016-2026 Asia & Pacific Anti-Infective Vaccines Market Size
Figure 2016-2026 Asia & Pacific Anti-Infective Vaccines Market Size and CAGR
Table 2016-2026 Asia & Pacific Anti-Infective Vaccines Market Size by Application
Table 2016-2021 Asia & Pacific Anti-Infective Vaccines Key Players Revenue
Table 2016-2021 Asia & Pacific Anti-Infective Vaccines Key Players Market Share
Table 2016-2026 Asia & Pacific Anti-Infective Vaccines Market Size by Type
Table 2016-2026 China Anti-Infective Vaccines Market Size
Table 2016-2026 India Anti-Infective Vaccines Market Size
Table 2016-2026 Japan Anti-Infective Vaccines Market Size
Table 2016-2026 South Korea Anti-Infective Vaccines Market Size
Table 2016-2026 Southeast Asia Anti-Infective Vaccines Market Size
Table 2016-2026 Australia Anti-Infective Vaccines Market Size
Table 2016-2026 Europe Anti-Infective Vaccines Market Size
Figure 2016-2026 Europe Anti-Infective Vaccines Market Size and CAGR
Table 2016-2026 Europe Anti-Infective Vaccines Market Size by Application
Table 2016-2021 Europe Anti-Infective Vaccines Key Players Revenue
Table 2016-2021 Europe Anti-Infective Vaccines Key Players Market Share
Table 2016-2026 Europe Anti-Infective Vaccines Market Size by Type
Table 2016-2026 Germany Anti-Infective Vaccines Market Size
Table 2016-2026 France Anti-Infective Vaccines Market Size
Table 2016-2026 United Kingdom Anti-Infective Vaccines Market Size
Table 2016-2026 Italy Anti-Infective Vaccines Market Size
Table 2016-2026 Spain Anti-Infective Vaccines Market Size
Table 2016-2026 Belgium Anti-Infective Vaccines Market Size
Table 2016-2026 Netherlands Anti-Infective Vaccines Market Size
Table 2016-2026 Austria Anti-Infective Vaccines Market Size
Table 2016-2026 Poland Anti-Infective Vaccines Market Size
Table 2016-2026 Russia Anti-Infective Vaccines Market Size
Table 2016-2026 MEA Anti-Infective Vaccines Market Size
Figure 2016-2026 MEA Anti-Infective Vaccines Market Size and CAGR
Table 2016-2026 MEA Anti-Infective Vaccines Market Size by Application
Table 2016-2021 MEA Anti-Infective Vaccines Key Players Revenue
Table 2016-2021 MEA Anti-Infective Vaccines Key Players Market Share
Table 2016-2026 MEA Anti-Infective Vaccines Market Size by Type
Table 2016-2026 Egypt Anti-Infective Vaccines Market Size
Table 2016-2026 Israel Anti-Infective Vaccines Market Size
Table 2016-2026 South Africa Anti-Infective Vaccines Market Size
Table 2016-2026 Gulf Cooperation Council Countries Anti-Infective Vaccines Market Size
Table 2016-2026 Turkey Anti-Infective Vaccines Market Size
Table 2016-2021 Global Anti-Infective Vaccines Market Size by Region
Table 2016-2021 Global Anti-Infective Vaccines Market Size Share by Region
Table 2016-2021 Global Anti-Infective Vaccines Market Size by Application
Table 2016-2021 Global Anti-Infective Vaccines Market Share by Application
Table 2016-2021 Global Anti-Infective Vaccines Key Vendors Revenue
Figure 2016-2021 Global Anti-Infective Vaccines Market Size and Growth Rate
Table 2016-2021 Global Anti-Infective Vaccines Key Vendors Market Share
Table 2016-2021 Global Anti-Infective Vaccines Market Size by Type
Table 2016-2021 Global Anti-Infective Vaccines Market Share by Type
Table 2021-2026 Global Anti-Infective Vaccines Market Size by Region
Table 2021-2026 Global Anti-Infective Vaccines Market Size Share by Region
Table 2021-2026 Global Anti-Infective Vaccines Market Size by Application
Table 2021-2026 Global Anti-Infective Vaccines Market Share by Application
Table 2021-2026 Global Anti-Infective Vaccines Key Vendors Revenue
Figure 2021-2026 Global Anti-Infective Vaccines Market Size and Growth Rate
Table 2021-2026 Global Anti-Infective Vaccines Key Vendors Market Share
Table 2021-2026 Global Anti-Infective Vaccines Market Size by Type
Table 2021-2026 Anti-Infective Vaccines Global Market Share by Type
Research Methodology:
Anti-Infective Vaccines Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|